Diagnostics products developer Autobio Diagnostics plans to invest $29.33m in purchasing 75% stake in Beijing Bio-Top, an in-vitro diagnostics company based in Beijing, China.
Urological medical devices developer MedicaMetrix will be acquired by Cardiff International in a $6m all-stock transaction.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The target company will merge into Cardiff and will operate as its subsidiary.
The acquisition enables Cardiff, a software systems developer, to enter the medical device field.
Sygnis AG intends to acquire Innova Biosciences for a purchase consideration of approximately $10m, which will be paid through $8.79m in cash and will issue up to 3.5 million shares.
The acquirer company expects the acquisition to strengthen its portfolio with a labelling technology lightning link.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSygnis is a molecular biology company involved in the development of novel products, while Innova Biosciences offers bioconjugation technologies and services.
Luxendo GmbH has been acquired by Bruker Corporation in a move to expand its fluorescence microscopy portfolio.
Luxendo is engaged in developing advanced single plane illumination microscopes (SPIM), while Bruker is a provider of scientific instruments and diagnostic solutions.
In a $2.99m deal, MG Med intends to acquire 17.1% stake in Oxford Cancer Biomarkers.
MG Med is engaged in molecular diagnostics, while Oxford Cancer Biomarkers is a developer of biomarker diagnostic products.
